Physician

Ryan Brett Moody, M.D

According to 2025 Medicare claims, Ryan Moody, M.D (NPI: 1629191853) practices pulmonary disease in the Savannah, GA market, with the plurality of this provider's patient population coming from Chatham, GA. This provider's primary affiliated billing organization is SOUTHEAST LUNG & CRITICAL CARE SPECIALISTS, P.C. (NPI: 1740244276; TIN: 58-2362019) and primary practice location at 31406-1523.

Moody's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,137 traditional Medicare patients, billed 7,994 HCPCS/CPT codes, and received $445,583 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,232 prescription claims across 645 beneficiaries totaling $4,436,436 in drug costs, led by Opsumit (Macitentan). DME data shows 5,244 claims. Open Payments data shows 154 records totaling $11,053. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $788,917 to $4,436,436. For DME billing, reported payments moved from a lower plateau to a higher plateau, from $160,701 to $325,657.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	989	5,544	$339,457
2016	1,010	5,272	$356,751
2017	1,064	5,968	$370,979
2018	1,211	6,484	$371,140
2019	1,228	6,622	$366,557
2020	1,213	5,119	$307,642
2021	1,237	4,615	$292,944
2022	1,213	4,394	$267,315
2023	1,125	4,473	$282,382
2024	1,137	7,994	$445,583

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	330	1,849	$788,917
2016	317	1,819	$1,008,433
2017	387	2,392	$869,315
2018	419	2,331	$1,512,459
2019	517	2,570	$1,881,770
2020	543	2,920	$2,002,438
2021	537	2,800	$2,374,126
2022	579	2,912	$2,509,550
2023	636	3,181	$3,923,274
2024	645	3,232	$4,436,436

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	780	2,346	$188,454
2016	867	2,606	$132,670
2017	986	2,789	$153,027
2018	1,094	3,476	$226,774
2019	1,395	4,027	$266,372
2020	1,779	5,069	$402,595
2021	1,923	5,541	$423,009
2022	1,855	5,194	$379,596
2023	2,004	5,834	$424,725
2024	1,698	5,244	$371,594

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	666	1,137	$91
94729	Test to examine how well the lungs exchange gases	404	405	$38
94727	Test to determine lung volumes using gas dilution or washout	405	406	$31
94010	Test to measure expiratory airflow and volume	308	326	$19
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	416	561	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Opsumit	Macitentan	56	1,680	$710,057
Uptravi	Selexipag	35	1,050	$698,945
Adempas	Riociguat	32	900	$418,878
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	489	19,770	$415,997
Ofev	Nintedanib Esylate	32	960	$413,665

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	14	98	$89,300
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	99	776	$62,383
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	59	$44,872
A7030	Full face mask used with positive airway pressure device, each	N	105	267	$23,064
A7031	Face mask interface, replacement for full face mask, each	N	95	247	$22,593

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	154	$11,053	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ryan Brett Moody, M.D?

Tedicare shows public-source Medicare data for Ryan Brett Moody, M.D (NPI 1629191853), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ryan Brett Moody, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ryan Brett Moody, M.D?

Ryan Brett Moody, M.D is linked to SOUTHEAST LUNG & CRITICAL CARE SPECIALISTS, P.C. (billing NPI 1740244276) in the available physician profile data.

Does Ryan Brett Moody, M.D have Open Payments data?

Ryan Brett Moody, M.D has 154 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.